The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer.

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

While the role of T helper 17 lymphocytes (Th17) in the pathogenesis of autoimmune diseases and in infectious immunity has been relatively well defined, the impact of these cells and their associated cytokines on cancer development is still under debate. Although multiple reports have indicated that Th17 can promote anticancer immunity, others have argued that these cells may exhibit tumor-promoting properties. This dichotomy in the function of Th17 lymphocytes in cancer may be related to the versatile nature of these cells, being capable of differentiating into either proinflammatory Th1 or suppressive FoxP3-expressing Treg cells or hybrid T cell subsets depending on the underlying environmental conditions. In the current review, we examine the role of Th17 lymphocytes and Th17-associated cytokines in cancer and discuss how factors that control their final lineage commitment decision may influence the balance between their tumor-promoting versus tumor-suppressing properties.

Original languageEnglish (US)
Pages (from-to)957878
Number of pages1
JournalClinical & developmental immunology
Volume2013
StatePublished - 2013

Fingerprint

Helper-Inducer T-Lymphocytes
Lymphocytes
Cytokines
Neoplasms
Immunity
Hybrid Cells
T-Lymphocyte Subsets
Regulatory T-Lymphocytes
Autoimmune Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{7f65e939f75547d5a3855a12734b54a6,
title = "The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer.",
abstract = "While the role of T helper 17 lymphocytes (Th17) in the pathogenesis of autoimmune diseases and in infectious immunity has been relatively well defined, the impact of these cells and their associated cytokines on cancer development is still under debate. Although multiple reports have indicated that Th17 can promote anticancer immunity, others have argued that these cells may exhibit tumor-promoting properties. This dichotomy in the function of Th17 lymphocytes in cancer may be related to the versatile nature of these cells, being capable of differentiating into either proinflammatory Th1 or suppressive FoxP3-expressing Treg cells or hybrid T cell subsets depending on the underlying environmental conditions. In the current review, we examine the role of Th17 lymphocytes and Th17-associated cytokines in cancer and discuss how factors that control their final lineage commitment decision may influence the balance between their tumor-promoting versus tumor-suppressing properties.",
author = "Darya Alizadeh and Emmanuel Katsanis and Nicolas Larmonier",
year = "2013",
language = "English (US)",
volume = "2013",
pages = "957878",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer.

AU - Alizadeh, Darya

AU - Katsanis, Emmanuel

AU - Larmonier, Nicolas

PY - 2013

Y1 - 2013

N2 - While the role of T helper 17 lymphocytes (Th17) in the pathogenesis of autoimmune diseases and in infectious immunity has been relatively well defined, the impact of these cells and their associated cytokines on cancer development is still under debate. Although multiple reports have indicated that Th17 can promote anticancer immunity, others have argued that these cells may exhibit tumor-promoting properties. This dichotomy in the function of Th17 lymphocytes in cancer may be related to the versatile nature of these cells, being capable of differentiating into either proinflammatory Th1 or suppressive FoxP3-expressing Treg cells or hybrid T cell subsets depending on the underlying environmental conditions. In the current review, we examine the role of Th17 lymphocytes and Th17-associated cytokines in cancer and discuss how factors that control their final lineage commitment decision may influence the balance between their tumor-promoting versus tumor-suppressing properties.

AB - While the role of T helper 17 lymphocytes (Th17) in the pathogenesis of autoimmune diseases and in infectious immunity has been relatively well defined, the impact of these cells and their associated cytokines on cancer development is still under debate. Although multiple reports have indicated that Th17 can promote anticancer immunity, others have argued that these cells may exhibit tumor-promoting properties. This dichotomy in the function of Th17 lymphocytes in cancer may be related to the versatile nature of these cells, being capable of differentiating into either proinflammatory Th1 or suppressive FoxP3-expressing Treg cells or hybrid T cell subsets depending on the underlying environmental conditions. In the current review, we examine the role of Th17 lymphocytes and Th17-associated cytokines in cancer and discuss how factors that control their final lineage commitment decision may influence the balance between their tumor-promoting versus tumor-suppressing properties.

UR - http://www.scopus.com/inward/record.url?scp=84905364820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905364820&partnerID=8YFLogxK

M3 - Article

C2 - 24454480

AN - SCOPUS:84905364820

VL - 2013

SP - 957878

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

ER -